Results for tag: "Kyprolis"

Kyprolis (carfilzomib) is a prescription medication used to treat multiple myeloma, a type of cancer that affects the bone marrow. It is a proteasome inhibitor, meaning it works by blocking the activity of proteasomes, which are proteins that help cancer cells survive and grow. Kyprolis is used in combination with other drugs to treat multiple myeloma that has not responded to other treatments. It is also used to treat relapsed multiple myeloma, which is when the cancer has come back after being treated. Kyprolis is part of a larger market of leukemia drugs, which are used to treat various types of leukemia, including acute myeloid leukemia, chronic myeloid leukemia, and acute lymphoblastic leukemia. These drugs work by targeting the cancer cells and stopping them from growing and spreading. They can also be used to reduce symptoms and improve quality of life. The companies in the Kyprolis market include Amgen, Onyx Pharmaceuticals, and Takeda Pharmaceuticals. Show Less Read more